ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,877Medicare Part D Prescriptions Filled, Including Refills

Rank: 112 out of 337

$654K Total Retail Price of All Prescriptions

Rank: 35 out of 337

267 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
48% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Rhode Island
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 267 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

13% of this provider’s 267 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

0% of this provider’s 5,802 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$83 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Rhode Island
AMLODIPINE BESYLATE 346 316 1 3
WARFARIN SODIUM 334 325 2 11
LISINOPRIL 261 221 3 2
SIMVASTATIN 246 217 4 1
OMEPRAZOLE 239 186 5 4
LEVOTHYROXINE SODIUM 215 178 6 5
FUROSEMIDE 204 175 7 8
LOSARTAN POTASSIUM 183 150 8 15
METOPROLOL TARTRATE 173 164 9 6
HYDROCHLOROTHIAZIDE 171 138 10 9
SERTRALINE HCL 158 127 11 18
ATORVASTATIN CALCIUM 152 109 12 7
ATENOLOL 149 104 13 10
HYDROCODONE-ACETAMINOPHEN 138 66 S3 14 13
METFORMIN HCL 120 82 15 12
DONEPEZIL HCL 119 119 16 22
TRAZODONE HCL 103 46 17 16
ALENDRONATE SODIUM 98 93 18 19
NAMENDA 84 84 19 35
PANTOPRAZOLE SODIUM 80 41 20 36
PRAVASTATIN SODIUM 78 55 21 14
GABAPENTIN 67 47 22 20
PROAIR HFA 66 18 23 38
GLIMEPIRIDE 65 47 24 55
ADVAIR DISKUS 63 53 25 44
LOVASTATIN 62 50 26 24
FENOFIBRATE 60 42 27 48
MIRTAZAPINE 60 60 27 27
ALLOPURINOL 57 56 29 28
CITALOPRAM HBR 57 42 29 17
QUETIAPINE FUMARATE 54 51 31 61
GLIPIZIDE 52 52 32 45
CARVEDILOL 51 51 33 73
ZOLPIDEM TARTRATE 51 26 33 23
CRESTOR 50 26 35 29
DIOVAN 50 46 35 26
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 7, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.